Name: Cartesian Therapeutics, Inc. (RNAC) Balance Sheet
Creator: FinSpry

Cartesian Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Cartesian Therapeutics, Inc. (RNAC) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	212.61	76.91	106.44	128.06	138.69	89.89	37.40
Short-Term Investments	0.00	0.00	28.16	14.00	0.00	0.00	0.00
Cash & Short-Term Investments	212.61	76.91	134.60	128.06	138.69	89.89	37.40
Accounts Receivable	0.87	8.85	9.76	9.91	7.22	5.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	3.14	4.97	3.49	0.09	0.37	0.00	0.00
Total Current Assets	216.63	90.73	148.14	144.44	151.34	96.67	42.08
Non-Current Assets
Property, Plant & Equipment (Net)	15.45	12.18	14.41	11.97	12.34	1.52	2.13
Long-Term Investments	2.00	2.00	2.00	0.00	0.00	0.00	0.00
Goodwill	48.16	48.16	0.00	0.00	0.00	0.00	0.00
Intangible Assets	150.60	150.60	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	2.19	1.38	1.34	1.38	1.38	1.38	0.28
Total Non-Current Assets	218.40	214.32	17.75	15.35	13.72	2.90	2.41
Total Assets	435.02	305.05	165.89	159.88	165.44	99.57	44.48
Current Liabilities
Accounts Payable	0.29	18.72	0.32	11.36	8.59	13.99	12.68
Short-Term Debt	2.85	0.00	8.48	5.96	0.00	0.00	0.00
Current Portion of Long-Term Debt	0.00	0.00	8.48	0.00	0.00	0.00	0.00
Accrued Liabilities	12.08	14.73	14.08	10.53	0.00	0.00	0.00
Deferred Revenue	0.00	2.31	0.59	53.88	0.00	0.00	0.00
Other Current Liabilities	7.76	6.39	4.24	3.18	3.05	2.24	0.00
Total Current Liabilities	22.98	68.21	25.08	72.25	81.55	34.94	35.14
Non-Current Liabilities
Long-Term Debt	11.13	8.79	17.79	28.27	34.44	0.00	0.00
Deferred Tax Liabilities	16.14	15.85	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	387.74	362.30	19.14	65.30	110.80	16.35	0.94
Total Non-Current Liabilities	418.85	687.33	46.98	39.69	73.19	14.68	14.76
Total Liabilities	441.83	444.68	72.06	137.36	183.44	91.17	49.90
Stockholders' Equity
Common Stock	0.00	0.00	0.02	0.01	0.00	0.00	0.00
Retained Earnings	-692.07	-619.25	-394.94	-434.88	-409.19	-340.28	-280.40
Accumulated Other Comprehensive Income	-4.62	-4.60	-4.56	-4.57	0.00	0.00	-4.56
Additional Paid-in Capital	689.89	179.06	493.31	457.39	391.18	348.66	279.54
Shares Outstanding	25.77	5.40	5.10	4.12	0.00	0.00	0.00
Total Stockholders' Equity	-6.80	-440.18	93.83	47.94	10.70	49.95	-5.42
Total Liabilities & Equity	435.02	305.05	165.89	159.88	165.44	99.57	44.48